← 19 Aug 2026 · Long-term Top 10 — Health Care
Long-term Top 10 — Health Care — what changed on 20 Aug 2026
A dated record of one session: what entered or left, what moved inside the ten and by how much, who is closest to the boundary, and how the list did against its benchmark. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.
The long-term score is a published weighted sum of percentile ranks, rebalanced on the first trading day of each month. A list is a published formula and its output, not a recommendation. Method version 2.
Get this list's changes by email
Who entered, who left, and the reason — with the score moves behind it.
Informational only — not financial advice. The daily email has not started yet — subscribing now puts you on the list for the first one. Unsubscribe in one click.
Membership
No company entered or left on 20 Aug 2026. The next scheduled change is at this list's next rebalance.
Inside the ten
Against the previous session, 19 Aug 2026.
| Company | Rank | Score | Pillar that moved most |
|---|---|---|---|
| Lilly (Eli) (LLY) | 1 | 69.9 −0.2 | Long-term trend 84th → 83th |
| Amgen (AMGN) | 2 | 66.7 0.0 | Valuation 26th → 27th |
| NATIONAL HEALTHCARE CORP (NHC) | 3 +3 | 64.4 +2.4 | Valuation 50th → 63th |
| Johnson & Johnson (JNJ) | 4 −1 | 64.3 +0.1 | Valuation 29th → 31th |
| ResMed (RMD) | 5 −1 | 63.6 +0.3 | Valuation 53th → 54th |
| Bristol Myers Squibb (BMY) | 6 −1 | 62.1 −0.7 | Long-term trend 85th → 81th |
| Royalty Pharma (RPRX) | 7 | 61.5 −0.1 | Long-term trend 90th → 90th |
| LIGAND PHARMACEUTICALS INC (LGND) | 8 | 61.0 +0.1 | Long-term trend 73th → 74th |
| Quest Diagnostics (DGX) | 9 | 58.9 −0.2 | Valuation 49th → 48th |
| West Pharmaceutical Services (WST) | 10 | 57.9 +0.6 | Long-term trend 69th → 72th |
At the edge
Knocking
- Agilent Technologies (A) 0.3 below the lowest member
- Chemed Corporation (CHE) 0.6 below the lowest member
Closest to the exit
- LIGAND PHARMACEUTICALS INC (LGND) 5.4 above the score at rank 15, where the hold band ends
- Quest Diagnostics (DGX) 3.3 above the score at rank 15, where the hold band ends
- West Pharmaceutical Services (WST) 2.3 above the score at rank 15, where the hold band ends
Ranked against 56 eligible Health Care companies on this session. A company at the edge is a company near a boundary, not a prediction that it will cross one.
Against the benchmark
−1.4% since the previous session (2026-08-19), against −0.8% for SPY — 0.6 points behind the benchmark. Tracked since 2026-08-18.
+1.1% since 2026-08-18, against −0.6% for SPY — 1.7 points ahead of the benchmark. Tracked since 2026-08-18.
More
Informational only — NOT financial advice.